Kai Lamottke is co-founder of Bicoll GmbH, Munich where he holds a position as Managing Director. Since 2001 he is also appointed as General Manager and member of the Board of Directors of Bicoll Biotechnology (Shanghai) Co. Ltd. In his position Dr. Lamottke is responsible for initial client and partnership contacts.
Prior to joining Bicoll he was working for the rational drug discovery company, 4SC AG, establishing the combinatorial chemistry division as project leader.
Dr. Lamottke received his Ph.D.-grade from the University of Munich working on the total synthesis and biosynthesis of medical relevant natural active agents.
Maria Lamottke, Dr. oec. (k.e.n.) | Public Relations Management
Maria Lamottke joined Bicoll GmbH, Munich and Bicoll Biotechnology (Shanghai) Co. Ltd. as Public Relations Manager in December 2010. Maria Lamottke has a profound finance as well as investor relations background. She received her Ph.D. in finance and diploma in finance and credit working on households portfolio optimization and gained special insights in the investor relations at the stock market company in Russia.